Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+11.2M
-
Total reported value, excl. options
-
$312M
-
Value change
-
+$312M
-
Number of buys
-
58
-
Price
-
$28.99
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2019
59 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2019.
TransMedics Group, Inc. - Common Stock (TMDX) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 33.9M outstanding shares and own 33.08% of the company stock.
Largest 10 shareholders include ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), FMR LLC (2.37M shares), CREDIT SUISSE AG/ (651K shares), Zimmer Partners, LP (539K shares), JANUS HENDERSON GROUP PLC (519K shares), RTW INVESTMENTS, LP (507K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (369K shares), BlackRock Inc. (323K shares), VANGUARD GROUP INC (309K shares), and EMERALD ADVISERS, LLC (212K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.